------------------------ Yahoo! Groups Sponsor --------------------~-->
Get fast access to your favorite Yahoo! Groups. Make Yahoo! your home page
http://us.click.yahoo.com/dpRU5A/wUILAA/yQLSAA/H4xqlB/TM
--------------------------------------------------------------------~->

Pancreatic Cancer Screensaver Lifesaver Program Identifies New
Therapeutic Compounds

http://www.arizonabiotech.com/
http://groups.yahoo.com/group/biotech-news/

Millions of home computers link together to accelerate the drug
discovery process

10-26-2005

Phoenix, AZ, October 25, 2005-After just five months of operation,
the Pancreatic Cancer Screensaver Lifesaver program has identified
two compounds that show promise against pancreatic cancer. The
worldwide Screensaver Lifesaver program links together millions of
home computers with access to the Internet to help discover new
pancreatic cancer drugs by running a special screensaver when it's
idle. The Pancreatic Cancer Screensaver program was announced in
April 2005 by the National Foundation for Cancer Research (NFCR) led
by Franklin C. Salisbury, Jr., Dr. Graham Richards, Chairman of the
Oxford University Chemistry Department and Dr. Daniel Von Hoff,
Director of the NFCR Center for Targeted Cancer Therapies at the
University of Arizona in Tucson and the Translational Genomics
Research Institute (TGen).
"The outcome of this project is absolutely remarkable," said
Franklin C. Salisbury, Jr., president of the NFCR. "The computing
power of the Screensaver program is essential to accelerating the
search for new cancer therapies."

The program uses parallel computing power to assess the interactions
between small drug-like molecules and predetermined cancer-causing
targets, shaving up to three years off the drug discovery process.

The screensaver program includes a drug-design software application
that can be downloaded at www.grid.org. Each subscribing computer
receives an initial bundle of 100 molecules and a model of a target
protein. The program calculates the binding energy between the small
molecules and the targets. Typically a day later, after processing
is complete, the program sends the results back to a data center and
requests more molecules.

The pancreatic program has been running to identify compounds that
hit several newly identified protein targets in pancreatic cancer
(primarily kinases and phosphatases). After just five months, a
total of 917 potential chemical hits were identified and two
compounds in particular show promise in fighting pancreatic cancer.
The next step is to further perfect these compounds and bring them
into a clinical trial as soon as possible.

"This Lifesaver-Screensaver project targeting pancreatic cancer will
work to speed the drug development process by at least 3 years,
hopefully more," said Dr. Von Hoff, director of TGen's Translational
Drug Development Division.

The results from the Pancreatic Cancer Screensaver Lifesaver program
will be presented by TGen's Dr. Haiyong Han at an international
molecular targets meeting next month in Philadelphia.

# # #

About TGen
The mission of the Translational Genomics Research Institute (TGen)
is to make and translate genomic discoveries into advances in human
health. Translational genomics research is a relatively new field
employing innovative advances arising from the Human Genome Project
and applying them to the development of diagnostics, prognostics and
therapies for cancer, neurological disorders, diabetes and other
complex diseases. TGen is focused on personalized medicine and plans
to accomplish its goals through robust and disease-focused research.

About the National Foundation for Cancer Research (NFCR)
Since its founding, the NFCR has spent more than $218 million
funding basic science cancer research and prevention education
focused on understanding how and why cells become cancerous. NFCR is
dedicated to funding scientists who are discovering cancer's
molecular mysteries and translating these discoveries into therapies
that hold the hope for curing cancer. For more information visit
www.NFCR.org or call (800) 321-CURE.

About Oxford University
The University of Oxford is internationally renowned for the quality
and diversity of its research, with over 3000 academic staff and
3000 postgraduate students working on research. The Chemistry
Department at Oxford is the largest in the western world, graduating
over 80 PhD scientists each year. The Department boasts a dozen
Fellows of the Royal Society, and has produced four Nobel Laureates.

About the Arizona Cancer Center
The Arizona Cancer Center's mission is to prevent and cure cancer
through excellence in patient care, research, and education. The
Center, directed by David S. Alberts, M.D., is one of a small,
prestigious network of comprehensive cancer centers designated by
the National Cancer Institute (NCI). Comprehensive status is the
highest ranking the NCI gives to cancer centers. This special
designation means that the center focuses not only on basic science
research and clinical (patient-oriented) research, but also on
prevention, control, and population sciences.

http://www.arizonaentrepreneurs.com/
http://www.azhttp.com/
http://www.mail-archive.com/biotech-news@yahoogroups.com/
http://www.mail-archive.com/biotech-news@yahoogroups.com/maillist.html

http://www.arizonabiotech.com/
<a href="http://www.arizonabiotech.com/">Arizona Biotech</a>
http://groups.yahoo.com/group/biotech-news/
<a href="http://groups.yahoo.com/group/biotech-news/">Biotech News</a>
http://www.arizonaentrepreneurs.com/
<a href="http://www.arizonaentrepreneurs.com/">Arizona Entrepreneurs</a>
http://www.azhttp.com/
<a href="http://www.azhttp.com/">Arizona High Tech</a>

Yahoo! Groups Links

<*> To visit your group on the web, go to:
http://groups.yahoo.com/group/biotech-news/

<*> To unsubscribe from this group, send an email to:
biotech-news-unsubscribe@yahoogroups.com

<*> Your use of Yahoo! Groups is subject to:
http://docs.yahoo.com/info/terms/

Arizona Biotech

Biotech News

Arizona Entrepreneurs

Arizona High Tech